Health ❯ Healthcare

Mental Health

Dementia Psychiatry Depression Emotional Well-being Gender Dysphoria Transgender Health Stress Management Trauma Substance Abuse Patient Care

Lilly to Buy AtaiBeckley for $2.8 Billion to Add Psychedelic Depression Drugs

The deal gives Lilly control of a Breakthrough‑designated 5‑MeO‑DMT nasal spray, moving its development and regulation under a major drugmaker.

WHO Says Up to 45% of Dementia Risk Is Modifiable and Adds Air Pollution as a Target

GLP-1 Weight-Loss Drugs Cut Binge Eating Episodes but Evidence Remains Limited

Stories older than 24h

KFF Finds 12 Million People on Both Medicare and Medicaid Account for Disproportionate Program Costs

Norton Children's Opens Reimagined Family Room in Cancer Unit

Wegovy Pill Arrives in UK Private Market as Clinicians Flag Dosing and Safety Risks

Purified THC‑CBD Drug Cuts Agitation in End‑of‑Life Dementia, Trial Shows

Medical Examiner Confirms Blake Garrett Died of Acute Fentanyl Toxicity

Global Analysis Finds Dementia Risk Factors Vary by Country but Cluster Similarly

LatAm‑FINGERS Trial Shows Multidomain Program Boosts Cognition in Older Adults

Silo Pharma Raises $4 Million in Private Placement as Shares Fall 28%

Utah Revokes License of Provo Canyon School’s Springville Campus

Pentagon Dispensed Record Number of Erectile Dysfunction Prescriptions to Troops

Multimodal Biomarkers Predict Who Responds to Common Antidepressants but Not Which Drug Works Best

Mamdani Permanently Closes North Infirmary Command on Rikers Island

Large Hong Kong Sibling Study Finds No Link Between Prenatal Acetaminophen and Autism or ADHD

World Cup Crowds Shift Toward Wealthier Fans as Ticket Prices Soar

Daytime Bright Light Linked to Lower Dementia Risk

Study Finds Common GLP‑1 Use and Misuse Among People With Eating Disorders

Definium’s Oral LSD Pill Meets Primary Endpoint in Phase 3 Depression Trial